Provider review
Noom Med review
An explicit microdose track — billed in months that are four weeks long.
Medication, visits and coaching are one subscription price, so the medication cost is never broken out. And the recurring charge covers a four-week supply billed quarterly, so a year holds more of them than the monthly figure suggests.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
$79 intro, then $179/mo (4-week months)
Visit Noom MedPrice as published
Noom Med
$79 intro, then $179/mo (4-week months)
- Vs median
- $10/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- No low-dose price published
- Dispensed
- Compounded, an unnamed partner network
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
There is a real microdose track here rather than a smaller amount of a standard plan, pairing a clinician evaluation with the coaching app, and it leans on FDA-approved branded products where they are available — which is a meaningfully different risk profile from the compounded majority here. The cost is bundled: medication, clinical visits and coaching arrive as one subscription, so you cannot see what the medication itself costs, and the recurring rate after the intro period is above the cheapest flat options here. A branded-product focus also means insurance dependence and availability that shifts.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want behavioral coaching as a real part of the program, not an add-on
- You prefer FDA-approved branded products where they can be obtained
- You want one subscription rather than several line items to track
Look elsewhere if
- You want to know what the medication alone costs
- You are comparing on the lowest ongoing monthly rate
- You are budgeting by the calendar — the billing cycle is four weeks, not a month, so a year holds an extra charge
- You are pricing from the advertised entry figure, which buys the first supply rather than the ongoing one
- You need availability that does not move with brand supply and insurance
What it actually costs
Price as published
$79 intro, then $179/mo (4-week months)
- Vs median
- $10/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
54 of the 407 programs here price a small dose this way. Runs an explicit microdose track, but the medication cost is folded into a coaching subscription and never broken out.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Optional
- Pricing
- Varies by dose, plan or tier
What it does well
- Sells an explicitly named microdose product — the "Noom Microdose GLP-1 Rx Program" — rather than leaving a low dose to be negotiated inside a standard plan
- Offers FDA-approved branded products alongside compounded, and is FSA/HSA eligible
- Prints both the intro and the standing rate on the same price card, which most competitors do not do
- States the quarterly billing total ($537 per 12 weeks) rather than only the monthly-sounding figure
Pharmacy, labs and oversight
Noom Med says it uses an unnamed partner network, but does not say which one. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Noom Med publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses an unnamed partner network, but does not say which one.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Noom's Microdose GLP-1 Rx track pairs a clinician evaluation with its coaching app, and is one of the few mainstream programs to sell a product it actually calls a microdose rather than describing one. Noom offers FDA-approved branded products (Wegovy/Ozempic, Zepbound/Mounjaro) alongside compounded semaglutide where a clinician judges it appropriate. The bundle folds medication, clinical visits and coaching into a single subscription billed every 12 weeks, so the medication is never priced separately from the program.
The honest cons
THE MONTH IS FOUR WEEKS. Billing is $537 per 12 weeks recurring, which is about $2,327 a year against the $2,148 that "$179/month" implies — roughly 8.3% more than the headline reads
- $79 gets you the first 4-week supply, and the standing rate is $179/month
- Its microdose page prints the entry price three ways: $79 on the price card, $49 in the FAQ and '$79/month' in a footnote
- Coaching-subscription bundle, so the medication cost is never broken out from the program cost
- Branded-product focus can mean insurance dependence and shifting availability
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Noom Med is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Noom Med does. Both are partners: we may earn a commission if you start care through these links.
Partner
Wellorithm
Pricing not published
No low-dose price published
Partner
Oak
$250–$300/mo
No low-dose price published
Where this sits
#33 of 407
Ordered with the companies that pay us first, and Noom Med is not one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Microdosing from a pen
- What microdosing GLP-1 costs
- Pen click calculator
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HumeCare+
$199–$299/mo (gated)
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HumeCare+ review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.